← back to search

Silvana Galderisi

Utrecht University · NL
🔎 Find collaborators in Psychiatry and Mental health · Cognitive Neuroscience →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research interests include Schizophrenia (object-oriented programming), Psychology, Psychiatry, Clinical psychology, Neurocognitive, and Medicine.
h-index
citations
4,824
works
40
NIH funding
primary concept
email

Recent publications

Identification and treatment of individuals with childhood-onset and early-onset schizophrenia
European Neuropsychopharmacology 2024cited by 46position: middledoi
Clinician-Reported Negative Symptom Scales: A Systematic Review of Measurement Properties
Schizophrenia Bulletin 2024cited by 8position: middledoi
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)
The Lancet Psychiatry 2023cited by 45position: middledoi
Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders
Neuroscience Applied 2023cited by 32position: middledoi
The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties
Schizophrenia 2023cited by 26position: middledoi
Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies
Translational Psychiatry 2023cited by 24position: middledoi
Clinical Assessment Interview for Negative Symptoms (CAINS): A Systematic Review of Measurement Properties
Schizophrenia Bulletin 2023cited by 12position: middledoi
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
European Psychiatry 2022cited by 126position: lastdoi
The clinical characterization of the patient with primary psychosis aimed at personalization of management
World Psychiatry 2021cited by 268position: middledoi
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses
JAMA Psychiatry 2021cited by 167position: middledoi
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life”
Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021cited by 31position: middledoi
Accuracy of self-assessment of real-life functioning in schizophrenia
Schizophrenia 2021cited by 26position: middledoi
Prevention of Psychosis
JAMA Psychiatry 2020cited by 459position: middledoi
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study
European Psychiatry 2020cited by 49position: middledoi
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning
European Neuropsychopharmacology 2020cited by 46position: lastdoi
Factors influencing lithium versus valproate prescription preference in the maintenance treatment of bipolar patients: a report from the Italian Early Career Psychiatrists (SOPSI-GG)
International Journal of Psychiatry in Clinical Practice 2020cited by 9position: lastdoi
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice
Schizophrenia Bulletin 2019cited by 77position: middledoi
European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)
European Neuropsychopharmacology 2019cited by 51position: middledoi
The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial
Schizophrenia Research 2019cited by 35position: middledoi
Negative symptoms of schizophrenia: new developments and unanswered research questions
The Lancet Psychiatry 2018cited by 548position: firstdoi
Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia
JAMA Psychiatry 2018cited by 317position: firstdoi
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
The Lancet Psychiatry 2018cited by 196position: middledoi
Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia
Schizophrenia Bulletin 2018cited by 143position: middledoi
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses
Schizophrenia Research 2018cited by 71position: middledoi
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition
Acta Psychiatrica Scandinavica 2018cited by 65position: middledoi
Value of schizophrenia treatment I: The patient journey
European Psychiatry 2018cited by 54position: middledoi
The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia
Schizophrenia Research 2017cited by 60position: middledoi
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives
Psychological Medicine 2017cited by 53position: middledoi
Deconstructing Vulnerability for Psychosis: Meta-Analysis of Environmental Risk Factors for Psychosis in Subjects at Ultra High-Risk
European Psychiatry 2016cited by 304position: middledoi
The “Insight Paradox” in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression
Schizophrenia Bulletin 2016cited by 88position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2012–2024)Celso Arango · King's College London8 papers (2014–2024)Philip McGuire · McGill University6 papers (2015–2023)Stefan Leucht · KUKA (Germany)6 papers (2015–2024)Wolfgang Gäebel · Ludwig-Maximilians-Universität München5 papers (2013–2022) · 4 papers (2012–2020) · 4 papers (2015–2021)René S. Kahn · Bezirkskrankenhaus Augsburg4 papers (2012–2023)Mark J. Millan · AVL (France)3 papers (2016–2020)John M. Davis · University of Illinois Chicago3 papers (2023–2024)Peter Falkai · Klinik und Poliklinik für Psychiatrie und Psychotherapie3 papers (2013–2019)Birte Glenthøj · University of Copenhagen3 papers (2015–2023)Christoph U. Correll · Champlain Regional College3 papers (2019–2024)Paolo Fusar‐Poli · King's College London3 papers (2016–2020)Sophia Wehr · Technical University of Munich3 papers (2023–2024) · 3 papers (2020–2023)Lucia Weigel · Technical University of Munich3 papers (2023–2024)Andreas Meyer‐Lindenberg · Heidelberg University3 papers (2015–2020)Paola Dazzan · King's College London3 papers (2015–2023)Michael Bauer · Universität Hamburg2 papers (2016–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Psychiatry and Mental health · Cognitive Neuroscience →